As a sensitive and accurate quantitative test, the G6PD test provides a specific level of G6PD deficiency severity, and hence risk of haemolytic crisis from triggering factors, in line with World Health Organisation classifications. Also, unlike other G6PD assays, which require 30 minutes of sample preparation steps, the POINTE G6PD assay needs just a single 5-minute lysing step and can be on-board lysed, reducing the time to results for G6PD activity levels in whole blood.
The G6PD test can be performed either manually or uniquely automated onto a suitable open channel clinical chemistry analyser such as the HORIBA Pentra C400. This benchtop analyser will perform both routine and specific tests on a single, user-friendly system which offers 55 on-board assays with back-up availability. Automating the POINTE G6PD test on such a chemistry analyser, along with its 5-minute lysing step and the fact that it is an enzymatic method assay requiring no calibrator, all serve to streamline and deliver highly effective G6PD testing.
For more information, visit:
Digital issue: Please click here for more information